Modeling, unraveling, and beating acquired resistance to BCMA and GPRC5D targeted agents in multiple myeloma.

Funder: INTERNATIONAL MYELOMA SOCIETY (IMS)

Duration: from 01 May 2024 to 30 April 2025 (12 months) Finished

225,932.00 EUR

Of International (non-EU) scope.

Call: International Myeloma Society (IMS) and Paula and Rodger Riney Foundation Translational Research Award 2024 (INTERNATIONAL MYELOMA SOCIETY (IMS))

Researchers

Leader

Modeling, unraveling, and beating acquired resistance to BCMA and GPRC5D targeted agents in multiple myeloma.

Researchers Filter by first and last name Filter $(document).ready(function () { new FilterComponent("miembros/filtrar", "personas", "#miembros", ".proyecto-miembros__item").init(); });

Researchers